Delivering Medical Affairs Value Through Omnichannel Orchestration
Learnings from a roundtable discussion with Medical Affairs leadership from 11 pharma companies
Being KOL-Centric: More Meaningful Expert Engagement
Global medical affairs teams seek better support to manage relationships with key opinion leaders—and find that balance between patient needs, scientific objectives, and the interest areas of KOLs.
Industry Predictions For 2023
Top industry experts weigh in on what the new year holds for the pharma industry.
2 Commerce Drive Cranbury, NJ 08512